- Home
- PAR vs GPCR Comparison
PAR vs GPCR Comparison
Compare PAR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- GPCR
- Stock Information
- Founded
- PAR 1968
- GPCR 2016
- Country
- PAR United States
- GPCR United States
- Employees
- PAR N/A
- GPCR N/A
- Industry
- PAR Office Equipment/Supplies/Services
- GPCR
- Sector
- PAR Miscellaneous
- GPCR
- Exchange
- PAR Nasdaq
- GPCR Nasdaq
- Market Cap
- PAR 2.2B
- GPCR 1.8B
- IPO Year
- PAR N/A
- GPCR 2023
- Fundamental
- Price
- PAR $72.34
- GPCR $34.17
- Analyst Decision
- PAR Strong Buy
- GPCR Buy
- Analyst Count
- PAR 8
- GPCR 5
- Target Price
- PAR $77.38
- GPCR $86.80
- AVG Volume (30 Days)
- PAR 543.3K
- GPCR 677.5K
- Earning Date
- PAR 11-08-2024
- GPCR 11-13-2024
- Dividend Yield
- PAR N/A
- GPCR N/A
- EPS Growth
- PAR N/A
- GPCR N/A
- EPS
- PAR N/A
- GPCR N/A
- Revenue
- PAR $453,986,000.00
- GPCR N/A
- Revenue This Year
- PAR N/A
- GPCR N/A
- Revenue Next Year
- PAR $20.03
- GPCR N/A
- P/E Ratio
- PAR N/A
- GPCR N/A
- Revenue Growth
- PAR 49.11
- GPCR N/A
- 52 Week Low
- PAR $35.96
- GPCR $26.61
- 52 Week High
- PAR $76.10
- GPCR $66.38
- Technical
- Relative Strength Index (RSI)
- PAR 71.56
- GPCR 35.81
- Support Level
- PAR $58.45
- GPCR $33.85
- Resistance Level
- PAR $76.10
- GPCR $38.48
- Average True Range (ATR)
- PAR 2.54
- GPCR 2.62
- MACD
- PAR 0.88
- GPCR -0.36
- Stochastic Oscillator
- PAR 78.70
- GPCR 3.67
About PAR PAR Technology Corporation
PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.